Is systemic infliximab therapy effective for retinal cavernous hemangioma?

Authors

• Sulaiman M. Alsulaiman, Department of Ophthalmology, College of Medicine, King Saud University, Riyadh, Kingdom of Saudi Arabia. E-mail. dr.abouammoh{at}gmail.com
• Marwan A. Abouammoh, Department of Ophthalmology, College of Medicine, King Saud University, Riyadh, Kingdom of Saudi Arabia. E-mail. dr.abouammoh{at}gmail.com
• Saad A. Al-Dahmash, Department of Ophthalmology, College of Medicine, King Saud University, Riyadh, Kingdom of Saudi Arabia. E-mail. dr.abouammoh{at}gmail.com

Abstract

A 10-month-old infant with the diagnosis of retinal cavernous hemangioma involving the macula presented with an outward deviation of the right eye that has been noticed by her parents. Examination revealed a clearing vitreous hemorrhage, and grape-like clusters filled with blood in the posterior pole. After 4 cycles of intravenous infliximab over the period of 3 months, no evident change was noted on the size of the cavernous hemangioma.

Article Type

Case Report

First Page

1127

Last Page

1130

Recommended Citation

Alsulaiman, Sulaiman M.; Abouammoh, Marwan A.; and Al-Dahmash, Saad A. (2014) "Is systemic infliximab therapy effective for retinal cavernous hemangioma?," Saudi Medical Journal: Vol. 35: Iss. 9, Article 15.
DOI: https://doi.org/10.15537/1658-3175.6039